Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin plus dexamethasone for pain and mouth opening after mandibular third molar extraction
IRCT20240319061334N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of gabapentin and dexamethasone in postoperative pain and trismus (2 arms), sponsored by Islamic Azad University. Primary endpoints: Improvement of mouth opening after gabapentin premedication and Improvement of pain level after gabapentin premedication. Started Oct 2024; status: completed.
02
Drugs
gabapentindexamethasone
03
Conditions
postoperative paintrismus
Beyond the preview
Go deeper on IRCT20240319061334N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240319061334N1.